{
    "paper_id": "PMC7200048",
    "metadata": {
        "title": "Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy",
        "authors": [
            {
                "first": "F.",
                "middle": [
                    "Burcu"
                ],
                "last": "Belen-Apak",
                "suffix": "",
                "email": "draidabb@gmail.com",
                "affiliation": {}
            },
            {
                "first": "F.",
                "middle": [],
                "last": "Sar\u0131alio\u011flu",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "\nSARS-CoV2 binds to ACE2 receptors on type II pneumocytes and possibly on vascular endothelial cells and causes lysis of the cells immediately leading to direct activation of the endothelium causing procoagulant activity and activates accumulation of fibrin deposits in pulmonary microcapillary venous vessels. The fibrin deposits cause a compensatory mechanism of increased plasminogen at the beginning but as the disease progresses fail to break down the fibrin deposits reflected in increased d-dimer levels. The treatment strategy at this level should be blockage of hyper coagulation with low molecular weight heparin (LMWH) as mentioned by Thachil [1] for blocking thrombin and dampen the inflammatory response. LMWH at prophylactic doses should be administered to all symptomatic patients with microbiologically or radiologically documented COVID-19 diagnosis and escalated to therapeutic doses in case of respiratory distress.In case LMWH is insufficient of preventing further activation of PIC and the thromboses extend to pulmonary veins, the process will proceed to secondary pulmonary hypertension and cardiac insufficiency. Increased intravascular pressure in lungs will result in extensive alveolar exudation resulting causing marked hypoxia. As a consequence of decreased pulmonary venous flow, the left ventricular stroke volume will decrease leading to systemic hypotension. The treatment option at this step should be Tissue Plasminogen Activator (TPA) or defibrotide. These two fibrinolytic modalities can prevent intubation and progression to DIC (Fig. 1). Plasminogen and TPA has been used in COVID-19 patients in a few studies and have been shown to be beneficial in improving respiratory capacity [7, 8]. As the immune-pathogenesis seems to resemble endothelial dysfunction of sinusoidal obstruction syndrome we think that defibrotide can also be useful or its pro-fibrinolytic, antithrombotic, thrombolytic, anti-ischemic and anti-inflammatory functions that may help to restore the endothelial function [9]. According to the previous literature, we think the major pathogenesis of COVID-19 disease starts with hyper coagulation and PIC. We believe that early anticoagulation and early thrombolytic agents may provide better prognosis in these patients.\n",
            "cite_spans": [
                {
                    "start": 655,
                    "end": 656,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 1721,
                    "end": 1722,
                    "mention": "7",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 1724,
                    "end": 1725,
                    "mention": "8",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 2029,
                    "end": 2030,
                    "mention": "9",
                    "ref_id": "BIBREF8"
                }
            ],
            "section": "Possible pathogenesis and treatment strategy",
            "ref_spans": [
                {
                    "start": 1573,
                    "end": 1574,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "\n\n",
            "cite_spans": [],
            "section": "Possible pathogenesis and treatment strategy",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Fig. 1: The possible pathogenesis of COVID-19. TPA tissue plasminogen activator, aPTT activated partial thromboplastin time, PT prothrombin time, HLH hemophagocytic lymphohistiocytosis, MAS macrophage activating syndrome, LMWH low molecular weight heparin",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "The versatile heparin in COVID-19",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Thachil",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Thromb Haemost",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1111/jth.14821"
                ]
            }
        },
        "BIBREF1": {
            "title": "Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Thromb Haemost",
            "volume": "18",
            "issn": "4",
            "pages": "844-847",
            "other_ids": {
                "DOI": [
                    "10.1111/jth.14768"
                ]
            }
        },
        "BIBREF2": {
            "title": "Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Thromb Haemost",
            "volume": "18",
            "issn": "",
            "pages": "844-847",
            "other_ids": {
                "DOI": [
                    "10.1111/jth.14768"
                ]
            }
        },
        "BIBREF3": {
            "title": "Why the immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia are distinct from macrophage activation syndrome with disseminated Intravascular coagulation",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "McGonagle",
                    "suffix": ""
                },
                {
                    "first": "JS",
                    "middle": [],
                    "last": "O\u2019Donnell",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sharif",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Emery",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bridgewood",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Autoimmun Rev",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.autrev.2020.102537"
                ]
            }
        },
        "BIBREF4": {
            "title": "Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans",
            "authors": [
                {
                    "first": "SE",
                    "middle": [],
                    "last": "Fox",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Akmatbekov",
                    "suffix": ""
                },
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Harbert",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                },
                {
                    "first": "RS",
                    "middle": [],
                    "last": "Vander Heide",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "MedRxiv",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1101/2020.04.06.20050575"
                ]
            }
        },
        "BIBREF5": {
            "title": "Pulmonary pathology of early-phase, 2019 novel Coronavirus (COVID-19) pneumonia in two patients with lung cancer",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tian",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Niu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Xiao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Thorac Oncol",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.jtho.2020.02.010"
                ]
            }
        },
        "BIBREF6": {
            "title": "Is there a role for plasminogen activator (tPA) as a novel treatment for refractory COVID-19 associated with acute respiratory distress syndrome (ARDS)?",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "CD",
                    "middle": [],
                    "last": "Barrett",
                    "suffix": ""
                },
                {
                    "first": "EE",
                    "middle": [],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "RC",
                    "middle": [],
                    "last": "McIntyre",
                    "suffix": ""
                },
                {
                    "first": "PK",
                    "middle": [],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "DS",
                    "middle": [],
                    "last": "Talmar",
                    "suffix": ""
                },
                {
                    "first": "FA",
                    "middle": [],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "MB",
                    "middle": [],
                    "last": "Yaffe",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Trauma Acute Care Surg",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1097/TA.0000000000002694"
                ]
            }
        },
        "BIBREF7": {
            "title": "Plasminogen improves lung lesions and hypoxemia in patients with COVID-19",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ge",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "QJM",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1093/qjmed/hcaa121"
                ]
            }
        },
        "BIBREF8": {
            "title": "Defibrotide: properties and clinical use of an old/new drug",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Pescador",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Capuzzi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mantovani",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Fulgenzi",
                    "suffix": ""
                },
                {
                    "first": "ME",
                    "middle": [],
                    "last": "Ferrero",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Vascul Pharmacol",
            "volume": "59",
            "issn": "",
            "pages": "1-10",
            "other_ids": {
                "DOI": [
                    "10.1016/j.vph.2013.05.001"
                ]
            }
        }
    }
}